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Background: Some studies have shown that endoscopist specialty is associated with colorectal cancers missed by
colonoscopy. We sought to examine the relationship between endoscopist specialty and polypectomy rate, a
colonoscopy quality indicator. Polypectomy rate is defined as the proportion of colonoscopies that result in the
removal of one or more polyps.
Methods: A cross-sectional study was conducted of endoscopists and their patients from 7 Montreal and 2 Calgary
endoscopy clinics. Eligible patients were aged 50–75 and covered by provincial health insurance. A patient
questionnaire assessed family history of colorectal cancer, history of large bowel conditions and symptoms, and
previous colonoscopy. The outcome, polypectomy status, was obtained from provincial health administrative
databases. For each city, Bayesian hierarchical logistic regression was used to estimate the odds ratio for
polypectomy comparing surgeons to gastroenterologists. Model covariates included patient age, sex, family history
of colorectal cancer, colonoscopy indication, and previous colonoscopy.
Results: In total, 2,113 and 538 colonoscopies were included from Montreal and Calgary, respectively.
Colonoscopies were performed by 38 gastroenterologists and 6 surgeons in Montreal, and by 31
gastroenterologists and 5 surgeons in Calgary. The adjusted odds ratios comparing surgeons to gastroenterologists
were 0.48 (95% CI: 0.32–0.71) in Montreal and 0.73 (95% CI: 0.43–1.21) in Calgary.
Conclusions: An association between endoscopist specialty and polypectomy was observed in both cities after
adjusting for patient-level covariates. Results from Montreal suggest that surgeons are half as likely as
gastroenterologists to remove polyps, while those from Calgary were associated with a wide, non-significant
Bayesian credible interval. However, residual confounding from patient-level variables is possible, and further
investigation is required.
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Colorectal cancer (CRC) screening programs are either
in preparation or ongoing in all Canadian provinces and
many developed countries [1]. Colonoscopy is central to
CRC screening, and colonoscopy quality assurance
initiatives are underway in several countries [2-4]. Mea-
sures of quality in colonoscopy, such as cecal intubation
rate, colonoscope withdrawal time, and adenoma detection
rate (ADR) [5,6], vary substantially among endoscopists* Correspondence: maida.sewitch@mcgill.ca
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reproduction in any medium, provided the or[7-10]. The establishment of benchmarks for these quality
indicators aims to standardize colonoscopy practice
quality.
Of the many quality indicators identified, only ADR
has been shown to independently predict CRC diagnosis
after colonoscopy, an important public health outcome
that suggests failure of screening [11]. However, ADR is
difficult to assess using population-based data due to the
lack of pathology report information in health adminis-
trative databases. Polypectomy rate, the proportion of
colonoscopies that result in the removal of one or more
polyps, has been proposed as an alternative quality indi-
cator because it is known at the time of colonoscopy,
strongly correlated with ADR, and available from healthtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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polypectomy rates have been proposed [12,14].
Some studies have shown endoscopist specialty to be
associated with cancers missed by colonoscopy [15-18],
raising concerns about training and quality assurance.
Polypectomy rate is an upstream marker of quality
because failure to remove and diagnose pre-cancerous
and cancerous lesions leads to missed cancers. It is con-
ceivable, therefore, that differences in missed cancers
between specialties may originate with specialty differ-
ences in polypectomy rates. The relationship between
endoscopist specialty and polypectomy rate has not been
examined. If this relationship echoes that between spe-
cialty and missed cancers, this finding would lend sup-
port to the usefulness of polypectomy rate as a quality
indicator.
The objectives of the present study were to determine
whether there is a difference in polypectomy rates be-
tween surgeons and gastroenterologists beyond what is
attributable to differences in patient risk profiles, and to




We conducted a cross-sectional analysis combining data
from 2 prospective cohort studies. Recruitment for the
first cohort occurred between January and March 2007
in Montreal and Calgary for the purpose of developing
an administrative data algorithm to identify screening
colonoscopies. The second cohort was recruited between
January 2008 and March 2009 in Montreal to provide
additional subjects for the purpose of the present study.
Seven hospitals participated in Montreal: Royal Victoria
Hospital, Montreal General Hospital, St. Mary’s Hospital
Centre, Jewish General Hospital, Hôpital Maisonneuve-
Rosemont, Hôpital Fleury, and Centre hospitalier de
l’Université de Montréal. Two institutions participated
in Calgary: Foothills Medical Centre and Peter Lougheed
Centre. The same data collection methods were used for
both cohorts and at all sites. Ethics approval was
obtained from the McGill University Faculty of Medicine
Institutional Review Board and the research ethics
boards at each study site.
Data collection
Participating physicians were staff endoscopists at the
study hospitals with provincial health insurance billing
privileges for colonoscopy. A research assistant approached
consecutive patients who were waiting for their colonos-
copy with a study physician in the endoscopy waiting room
on select days. Eligible patients were aged 50–75 and cov-
ered by provincial health insurance. Reasons for not being
covered by provincial health insurance include being in themilitary or RCMP, being a treaty status Indian, and being a
resident of another province. The reason for this exclusion
criterion is that we were only able to link to provincial
records in Quebec and Calgary.
The research assistant explained the study, obtained
consent, and administered a brief questionnaire to pa-
tients on socio-demographics, history of gastrointestinal
conditions, large bowel symptoms, previous CRC screen-
ing tests, and family history of CRC.
Data on polypectomy status were obtained from phys-
ician billing records from the Régie de l’Assurance
Maladie du Québec (RAMQ) and Alberta Health and
Wellness (AHW). The Alberta ambulatory care database
also provided polypectomy status for Albertan patients.
For patients who underwent more than one colonoscopy
during the study period, we included only the first visit
in the analyses.
Statistical analyses
Bayesian hierarchical logistic regression models were fit-
ted to estimate the association between endoscopist spe-
cialty and polypectomy rate. This technique accounts for
endoscopist-level clustering, and allowed us to estimate
the odds ratio at the endoscopist level, while adjusting
for patient-level risk factors for CRC and adenoma,
including: age (50-54/55-59/60-64/65-70/70-75), sex, fa-
mily history of CRC (y/n), previous colonoscopy (y/n),
and colonoscopy indication (screening/non-screening).
Screening was defined as no history of large bowel
symptoms (rectal bleeding, unintentional weight loss,
abdominal pain) in the past 6 months, and no history of
gastrointestinal conditions (polyp, CRC diagnosis, in-
flammatory bowel disease, and previous bowel surgery).
To estimate the variability of polypectomy rates within
each specialty, endoscopist-specific rates were computed
from random intercepts for endoscopists. Covariates
were centered around their respective means, so that the
inverse logits of the intercepts yielded endoscopist-
specific rates for typical patients. All analyses were
conducted using WinBUGS software version 1.4.3 (MRC
Biostatistics Unit, Cambridge). Diffuse or wide prior dis-
tributions were used for all parameters in all models.
Ninety-five percent credible intervals, the Bayesian
equivalents of the frequentist confidence intervals, are
indicated by CrI.
We took measures to account for the imperfect accur-
acy of health administrative data. For Quebec, we
adjusted polypectomy rates using previously estimated
sensitivity, 84.7% (95% CI: 79–89%), and specificity,
99.0% (95% CI: 98–100%), of the RAMQ polypectomy
billing code [19]. The adjustment was done within the
WinBUGS model, where the adjusted rates were calcu-
lated from the rates estimated from the logistic model
[20]. For Alberta, overlapping polypectomy data sources
Table 1 Patient characteristics by city
Montreal Calgary
Patient Characteristic N (%) N (%)
Age, mean (sd) 60.1 (7.1) 59.7 (6.9)
Male 1059 (50.1) 248 (46.1)
Family history of CRCa 500 (23.6) 134 (24.9)
Colonoscopy in the past 10 years 988 (46.8) 189 (35.1)
Screeningb 855 (40.5) 208 (38.7)
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ambulatory care data. We considered a patient to have
had a polypectomy if the polypectomy code appeared in
either database; this a conservative approach because ad-
ministrative codes tend to have good specificity but poor
sensitivity [19,21]. Due to differences in the extent of
CRC screening, administrative data quality, and adjust-
ment methods, data from each city were analyzed separ-
ately rather than combined in a single model.History of gastrointestinal conditionsc 583 (27.6) 143 (26.6)
Large bowel symptoms in the past 6 monthsd 840 (39.8) 211 (39.2)
Total 2113 538
a CRC: colorectal cancer.
b Screening was defined as no history of gastrointestinal conditions and no
large bowel symptoms in the past 6 months.
c History of gastrointestinal conditions includes polyp, CRC diagnosis,
inflammatory bowel disease, and previous bowel surgery.
d Large bowel symptoms include rectal bleeding, unintentional weight loss,
abdominal pain in the past 6 months.
Table 2 Odds ratio estimates for polypectomy from
hierarchical logistic regression models for Montreal and
Calgary
Montreal Calgary
Variable ORa (95% CrI) ORa (95% CrI)
Endoscopist Level
Surgical specialtyb 0.48 (0.32–0.71) 0.73 (0.43–1.21)Results
Patient population
In Montreal, 2,134 (81.6%) of the 2,614 patients
approached were eligible and consented to participate.
A total of 38 gastroenterologists, 6 surgeons, and 1
internist performed 1,906 (89.3%), 207 (9.7%), and 21
(1%) colonoscopies, respectively. The patients seen by
the internist were excluded from further analysis, as
the sample size was too small to make inferences about
this specialty. Hence 44 endoscopists and 2,113 pa-
tients from Montreal were included. The average num-
ber of patients per endoscopist was 48, ranging from 4
to 154 among gastroenterologists, and 9 to 86 among
surgeons.
In Calgary, 541 (88.1%) of the 614 patients approached
were eligible and consented to participate. A total of 31
gastroenterologists and 5 colorectal surgeons performed
444 (82.1%) and 94 (17.4%) colonoscopies, respectively.
Three (0.6%) patients were excluded from analysis
because their colonoscopies were performed by trainees.
The final sample for Calgary included 37 endoscopists
and 538 patients. The average number of patients per
endoscopist was 15, and ranged from 1 to 73 among gas-
troenterologists, and from 6 to 30 among surgeons. Table 1




55–59 1.58 (1.17–2.15) 1.37 (0.82–2.31)
60–64 1.49 (1.09–2.04) 1.50 (0.84–2.62)
65–69 2.00 (1.45–2.78) 1.85 (0.96–3.356)
70–75 2.14 (1.53–3.01) 2.00 (1.06–3.76)
Male 1.85 (1.51–2.26) 1.93 (1.31–2.81)
Family History of CRCc 1.11 (0.87–1.41) 1.32 (0.84–2.07)
Colonoscopy in the past 10 years 0.75 (0.60–0.93) 0.68 (0.44–1.03)
Screeningd 0.86 (0.69–1.07) 0.79 (0.53–1.18)
a Odds ratio adjusted for all other covariates in the model.
b The reference category is gastroenterology.
c CRC: colorectal cancer.
d Screening was defined as no history of gastrointestinal conditions and no
large bowel symptoms in the past 6 months. The reference category is non-
screening, which was defined as having a history of gastrointestinal conditions
or large bowel symptoms.Results of hierarchical logistic regression
The hierarchical logistic regression results with polypec-
tomy as the outcome for Montreal and Calgary are shown
in Table 2. The odds ratios for polypectomy with surgeons
as compared to gastroenterologists, adjusted for patient
age, sex, family history of CRC, indication (screening vs.
non-screening), and previous colonoscopy were 0.48 (95%
CrI: 0.32–0.71) in Montreal and 0.73 (95% CrI: 0.43–1.21)
in Calgary.
To illustrate variability of polypectomy rates, endoscopist-
specific polypectomy rate estimates from hierarchical
logistic regression for each specialty are shown in Figure 1.
The estimates ranged from 6.0% (95% CrI: 0.30–19.6%) to
28.6% (95% CrI: 15.6–46.2%) among surgeons and from
12.3% (95% CrI: 3.9–25.9%) to 62.1% (95% CrI: 45.6–
78.9%) among gastroenterologists.Discussion
Using a combination of primary and health administrative
data from Montreal and Calgary, we estimated the associ-
ation between endoscopist specialty and polypectomy rate.
We found a clinically important difference between
endoscopist specialities in Montreal, with surgeons being
approximately 50% less likely than gastroenterologists to
remove polyps. A similar trend was observed in Calgary
A B
Figure 1 Histograms of endoscopist-specific polypectomy rates estimated from hierarchical logistic regression models among
A) gastroenterologists and B) surgeons. Models were adjusted for patient age (50-54/55-59/60-64/65-70/70-75), sex, family history of colorectal
cancer, colonoscopy in the past 10 years, and colonoscopy indication (screening was defined as no history of gastrointestinal conditions and no
lower abdominal symptoms in the past 6 months.). Covariates were centered such that the rates are interpretable as endoscopist-specific rates
for typical patients.
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sion. Patient risk factors yielded odds ratios consistent
with the literature, including increase in the probability of
polypectomy with increasing age. However, despite statis-
tical adjustment, residual confounding due to patient-level
risk factors may contribute the observed difference
between specialties.
Several prior studies have examined the association
between endoscopist speciality and missed CRCs. In a
retrospective cohort study using population level data
from Ontario, Bressler et al. identified endoscopist
specialty as a risk factor for incident CRCs post-
colonoscopy among both male and female patients [16].
In contrast to our study, the difference was found mainly
between gastroenterologists and primary care physicians,
rather than between gastroenterologists and surgeons.
This study also found that office colonoscopies are more
likely to be associated with missed lesions than hospital-
based colonoscopies. A Manitoba study also showed no
difference in missed cancers between surgeons and
gastroenterologists. This model included colonoscopy
volume and practice location (rural vs. urban) as covari-
ates, neither of which was significantly associated with
missed cancers [18]. Rabeneck et al. reported an odds
ratio of 1.39 (95% CI: 1.16–1.67) for the risk of CRC
diagnosis after negative colonoscopy in the patients seen
by surgeons vs. those seen by gastroenterologists in the
hospital setting [17]. Colonoscopy volume was not a pre-
dictor of missed cancers in this study. Baxter et al. used
administrative data from Ontario and found no differ-
ence between surgeons and gastroenterologists in post-
colonoscopy CRCs, but indicated that non-surgeon and
non-gastroenterologist specialties were at increased risk
for missed cancers [15]. Similar to previous findings,
practice setting was associated with post-colonoscopyCRCs, while colonoscopy volume was not. Only one of
the aforementioned studies that used post-colonoscopy
CRCs as an outcome detected a difference between sur-
geons and gastroenterologists. Although many of these
studies indicated a non-significant trend towards higher
rates of missed cancers among surgeons, the failure to
detect a statistically significant difference may have been
due to a lack of power because the outcome is rare. In
contrast to province-wide studies from Ontario and
Manitoba on endoscopy specialty and quality, our study
was restricted to urban hospitals and to ambulatory care
patients; thus, our findings are less generalizable. Never-
theless, in province-wide studies, the power to detect an
interaction between location and specialty may be of
concern, since the majority of colonoscopies are per-
formed by gastroenterologists in urban areas and by sur-
geons in rural areas [22].
We determined the variability in polypectomy rates
within each specialty, and found considerable variation
in both specialties. Several studies have reported import-
ant variation in ADRs by specialty. Barclay et al. exam-
ined 2,053 screening colonoscopies by 12 endoscopists
and found that ADRs varied from 9.4 to 32.7% [23].
Chen et al. studied the variation among 9 endoscopists
who performed 10,034 colonoscopies. After adjusting for
patient age and sex, detection rates for at least one aden-
oma ranged between 15.5 and 41.1% [24]. Imperiale
et al. found that ADRs ranged from 7% to 44% among
46 endoscopists who performed 2,664 screening colon-
oscopies [7]. Our results mirror those of others showing
variation in endoscopist performance, and further current
knowledge in that considerable variation exists between
as well as within specialties.
Our results suggest a clinically important differ-
ence in polypectomy rates between surgeons and
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as well as substantial variation among all endoscopists.
Some of this variation may be explained by endoscopist-
level factors such as training, practice factors, and tech-
nical factors. Recently, performance quality was compared
in trainees with similar endoscopy experience; gastro-
enterology trainees outperformed surgery trainees on sev-
eral quality indicators including colonoscopy completion
rate, polypectomy rate, ADR, and withdrawal time [10].
One Calgary study found that gastroenterology trainees
performed considerably more colonoscopies than surgery
trainees during their training [25]. Further, all of the
gastroenterology fellows fulfilled the minimum number of
colonoscopies recommended by the American Society for
Gastrointestinal Endoscopy for assessment of competency,
while none of the surgery residents did. These findings
suggest that differences in colonoscopy quality between
the two specialties may arise from differences in training.
Practice factors such as setting and annual case volume
may also contribute to variation among endoscopists. For
example, Bressler et al. and Baxter et al. both found non-
hospital based colonoscopies to be associated with
increased risk of missed cancers [15,16]. A recent study
from the U.K. showed that volume and accreditation were
significantly associated with colonoscopy quality indica-
tors [26]. Interestingly, in this study surgeons had a higher
polyp detection rate compared to physicians. However,
this difference was minimal after adjustment for patient-
level factors. Studies in Manitoba and Ontario have not
found colonoscopy volume to predict missed cancers
[15,17,18].
In terms of technical factors, withdrawal time has been
identified as a significant predictor of ADR in some
studies. Results from the Bowel Cancer Screening
Programme in England show a significant increase in
ADR among endoscopist with mean withdrawal time of
11 minutes or longer compared to those with mean
withdrawal time of less than 7 minutes [27]. Investiga-
tors in Spain examined bowel cleansing, sedation, cecal
intubation, and withdrawal time as potential predictors
of ADR. Only withdrawal time longer than 8 minutes
was independently associated with ADR [28]. However, a
German study found neither annual case volume nor
withdrawal time to be correlated with ADR [29]. The
mixed findings regarding practice and technical factors
that affect colonoscopy quality may be due to differences
in training, accreditation, practice settings, and CRC
screening delivery models between countries.
A major strength of our study is primary data collec-
tion on patient level CRC risk factors that enabled
adjustment for colonoscopy indication, family history of
CRC and previous colonoscopy. This is important be-
cause polypectomy rate is a function of both patient risk
and endoscopist performance.One study limitation is residual confounding. Al-
though we adjusted for many important patient risk
factors, it is possible that differences in the characteris-
tics of patients referred to surgeons and gastroenterolo-
gists were not adequately captured by the patient-level
covariates. A second limitation is potential misclassifica-
tion, as data on polypectomy status were derived from
provincial health administrative databases. To address
this issue, we employed methods to adjust for the imperfect
accuracy of health administrative data in both provinces.
Using health administrative data whilst acknowledging and
accounting for its limitations is good practice in clinical
and health services research. However, our approach to
misclassification adjustment for the Montreal data may
have introduced bias if misclassification was differential
between surgeons and gastroenterologists. Differences in
administrative data quality between specialties may arise
from differences in billing practices. Nevertheless, it is
reassuring that the Calgary sample, where misclassification
was reduced by combining two data sources, showed
results in the same direction as the Montreal sample.
Thirdly, hierarchical modeling was used to estimate the
rates as it has the advantage of conservatively bringing un-
stable estimates closer to the overall mean so that they are
less likely to affect the range of variation in polypectomy
rates [30]. While use of this statistical technique allowed us
to estimate the polypectomy rates of endoscopists with few
study patients, there were wide credible interval limits
around some individual estimates.
Although our findings highlight the important issue of
the discrepancy in quality between surgeons and gastro-
enterologists, the lack of endoscopist-level variables in
our study preclude us from isolating the modifiable pre-
dictors of endoscopist performance. Future studies
aimed at teasing out such factors would help inform
changes to training, accreditation, and quality assurance
programs. We hope that our findings will serve as im-
petus for such investigations.Conclusions
In conclusion, we found that surgeons were less likely
to remove polyps compared to gastroenterologists, and
that considerable variation in polypectomy rates exists
within each specialty. Using polypectomy rate as an in-
dicator of colonoscopy quality, our findings showed a
difference in practice quality between the two special-
ties despite controlling for variations in patient risk
profiles. Potential reasons for this discrepancy, such as
training, practice volume, and technical factors, need to
be investigated in future studies. Our findings suggest
that the difference in ADRs may begin at the level of
polyp removal, and lend further support for the use of
polypectomy rate as a colonoscopy quality indicator.
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